What question did this study set out to answer?

This research aims to evaluate the effects of continuing antipsychotic and benzodiazepine medications after ICU discharge.

April 16, 2026

View Full Paper

Impact of continuation of antipsychotic medications and benzodiazepines after critical care discharge

JIJohnny IsenbergerUniversity of Massachusetts Chan Medical School DCDawn CarpenterUniversity of Massachusetts Chan Medical School AMAlexander MenardUMass Memorial Health Care

Key Points

This research aims to evaluate the effects of continuing antipsychotic and benzodiazepine medications after ICU discharge.
Examined medication use among ICU survivors.
Analyzed prescribing practices of nurse practitioners.
Evaluated outcomes related to continued medication post-discharge.
Findings suggest reconsideration of antipsychotic and benzodiazepine prescriptions.
Indicates potential negative impacts on ICU survivors' recovery.

Abstract

Nurse practitioners should reevaluate the use of antipsychotics and/or benzodiazepines in the ICU and avoid discharging ICU survivors with a new prescription.

Demander à l'IA

Bookmark

View Full Paper

Demander à l'IA

Bookmark

View Full Paper

Impact of continuation of antipsychotic medications and benzodiazepines after critical care discharge

Key Points

Abstract

Cite This Study

Also Consider

Also Consider